BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16407231)

  • 1. Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors.
    Hales TG; Dunlop JI; Deeb TZ; Carland JE; Kelley SP; Lambert JJ; Peters JA
    J Biol Chem; 2006 Mar; 281(12):8062-71. PubMed ID: 16407231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.
    Peters JA; Kelley SP; Dunlop JI; Kirkness EF; Hales TG; Lambert JJ
    Biochem Soc Trans; 2004 Jun; 32(Pt3):547-52. PubMed ID: 15157181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptors.
    Peters JA; Carland JE; Cooper MA; Livesey MR; Deeb TZ; Hales TG; Lambert JJ
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):882-6. PubMed ID: 17052220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic analysis of the intracellular portals of the human 5-HT3A receptor.
    Carland JE; Cooper MA; Livesey MR; Hales TG; Peters JA; Lambert JJ
    J Biol Chem; 2013 Nov; 288(44):31592-601. PubMed ID: 24030822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals.
    Baptista-Hon DT; Deeb TZ; Lambert JJ; Peters JA; Hales TG
    J Biol Chem; 2013 Jul; 288(30):21558-68. PubMed ID: 23740249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors.
    Kelley SP; Dunlop JI; Kirkness EF; Lambert JJ; Peters JA
    Nature; 2003 Jul; 424(6946):321-4. PubMed ID: 12867984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.
    Lucero LM; Weltzin MM; Eaton JB; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
    J Biol Chem; 2016 Jan; 291(5):2444-59. PubMed ID: 26644472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
    Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
    J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep-related hypermotor epilepsy associated mutations uncover important kinetic roles of α4β2- nicotinic acetylcholine receptor intracellular structures.
    Weltzin MM; George AA; Lukas RJ; Whiteaker P
    PLoS One; 2021; 16(3):e0247825. PubMed ID: 33657187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles for nicotinic acetylcholine receptor subunit large cytoplasmic loop sequences in receptor expression and function.
    Kuo YP; Xu L; Eaton JB; Zhao L; Wu J; Lukas RJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):455-66. PubMed ID: 15833891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of nicotinic acetylcholine receptor β subunit cytoplasmic loops in acute desensitization and single-channel features.
    Liu Q; Kuo YP; Shen J; Lukas RJ; Wu J
    Neuroscience; 2015 Mar; 289():315-23. PubMed ID: 25536046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of alpha4beta2 nicotinic acetylcholine receptor trafficking.
    Ren XQ; Cheng SB; Treuil MW; Mukherjee J; Rao J; Braunewell KH; Lindstrom JM; Anand R
    J Neurosci; 2005 Jul; 25(28):6676-86. PubMed ID: 16014729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
    Hamouda AK; Deba F; Wang ZJ; Cohen JB
    Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse-Torpedo chimeric alpha-subunit used to probe channel-gating determinants on the nicotinic acetylcholine receptor primary sequence.
    Butler DH; Lasalde JA; Butler JK; Tamamizu S; Zimmerman G; McNamee MG
    Cell Mol Neurobiol; 1997 Feb; 17(1):13-33. PubMed ID: 9118205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.
    Gee VJ; Kracun S; Cooper ST; Gibb AJ; Millar NS
    Br J Pharmacol; 2007 Oct; 152(4):501-12. PubMed ID: 17721553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the lipid-protein interface of the alpha4beta2 neuronal nicotinic acetylcholine receptor: hydrophobic photolabeling studies with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine.
    Hamouda AK; Sanghvi M; Chiara DC; Cohen JB; Blanton MP
    Biochemistry; 2007 Dec; 46(48):13837-46. PubMed ID: 17994769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.
    Nichols WA; Henderson BJ; Marotta CB; Yu CY; Richards C; Dougherty DA; Lester HA; Cohen BN
    PLoS One; 2016; 11(6):e0158032. PubMed ID: 27336596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant
    Stokes C; Garai S; Kulkarni AR; Cantwell LN; Noviello CM; Hibbs RE; Horenstein NA; Abboud KA; Thakur GA; Papke RL
    J Pharmacol Exp Ther; 2019 Aug; 370(2):252-268. PubMed ID: 31175218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.